Skip to main content
SpringerLink
Log in

Gene Therapy for Prostate Cancer Bone Metastasis

Gene Therapy Targeting Bone Metastasis

  • Chapter
The Biology of Skeletal Metastases

Part of the book series: Cancer Treatment and Research ((CTAR,volume 118))

Abstract

Cancer is not a single cell disease but involves complex interaction between cancer cells and their microenvironment (Ingber, 2002; Liotta and Kohn, 2001; Quaranta, 2002; Shekhar et al., 2003; Sung and Chung, 2002). It has been widely recognized that the growth, survival and invasion of cancer cells require the participation of vascular endothelial component of the host (Folkman, 2001; Monsky et al., 2002), the inflammatory and neuroendocrine cells and their cytokine repertoire (Aprikian et al., 1994; Coussens and Werb, 2002; Murakami et al., 2002), and the inductive fibromuscular stromal cells (Aumuller, 1989; Franks et al., 1970; Tuxhorn et al., 2002). Experimental model systems to determine the molecular and cellular basis of prostate cancer progression to androgen independence and metastasis to bone revealed that intimate interaction between cancer cells and prostate or bone stromal cells is required (Chung et al., 1989; Gleave et al., 1991; Gleave et al., 1992; Olumi et al., 1998; Olumi et al., 1999). Under the inductive influence of prostate or bone stromal cells, the human LNCaP prostate cancer cell line can be driven to express both androgen-independent (AI) and bone metastatic potential when co-cultured in vitro as 3- dimensional (3-D) prostate organoids or allowed to form chimeric tumors when co-inoculated in vivo in castrated hosts (Rhee et al., 2001; Thalmann et al., 1994; Wu et al., 1994). These experiments demonstrated a fundamental principle that governs prostate cancer progression, the reciprocal interaction between genetically modified prostate cancer cells and the relevant fibromuscular stromal environment under androgen-deprived and 3-dimensional (3-D) growth conditions. Only in the presence of such interactions can the AI and bone metastatic progression of human prostate cancer cells be achieved. Apparently, permanent phenotypic and genotypic changes are induced in both prostate cancer and interactive stromal compartments (Hyytinen et al., 1997; Pathak et al, 1997). The consequences of cellular interaction include changes observed in the stroma, which becomes “reactive” and drives further progression of human prostate cancer cells to the AI and metastatic state (Sung and Chung, 2002). To tackle the molecular mechanisms underlying the progression of prostate cancer cells to androgen independence and bone metastasis under the influence of fibromuscular stromal cells, we and others have proposed that both soluble factors and insoluble extracellular matrices (ECMs) are likely to be involved through cellular communication or “cross-talk” between these mosaic factors, their receptors and downstream signaling pathways (Sung and Chung, 2002; Tuxhorn et al., 2001; Varani et al., 1999; Wong and Wang, 2000). In this review, we will focus our discussion on three areas: first, the development of the gene therapy concept and strategies to co-target prostate cancer growth in bone; second, the application of local-regional and systemic gene therapy in human clinical trials; and third, a discussion of the future development of effective gene therapy approaches for the treatment of prostate cancer bone metastasis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adachi, Y., Reynolds, P. N., Yamamoto, M., Grizzle, W. E., Overturf, K., Matsubara, S., Muramatsu, T. and Curiel, D. T. (2000): Midkine promoter-based adenoviral vector gene delivery for pediatric solid tumors. Cancer Research 60, 4305–10.

    PubMed  CAS  Google Scholar 

  • Anderson, W. F. (1998): Human gene therapy. Nature 392, 25–30.

    PubMed  CAS  Google Scholar 

  • Aprikian, A. G., Cordon-Cardo, C., Fair, W. R., Zhang, Z. F., Bazinet, M, Hamdy, S. M. and Reuter, V. E.(1994): Neuroendocrine differentiation in metastatic prostatic adenocarcinoma. Journal of Urology 151, 914–9.

    PubMed  CAS  Google Scholar 

  • Asano, M., Yukita, A., Matsumoto, T., Kondo, S. and Suzuki, H. (1995): Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factorl21. Cancer Research 55, 5296–301.

    PubMed  CAS  Google Scholar 

  • Ashley, D. M., Faiola, B., Nair, S., Hale, L. P., Bigner, D. D. and Gilboa, E. (1997): Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors. Journal of Experimental Medicine 186, 1177–82.

    PubMed  CAS  Google Scholar 

  • Aumuller, G. (1989): Morphologic and regulatory aspects of prostatic function. Anat Embryol (Berl) 179, 519–31.

    CAS  Google Scholar 

  • Bailey, S. M. and Hart, I. R. (1997): Nitroreductase activation of CB1954-an alternative’ suicide’ gene system. Gene Therapy 4, 80–1.

    PubMed  CAS  Google Scholar 

  • Bailey, S. M., Knox, R. J., Hobbs, S. M, Jenkins, T. C, Mauger, A. B., Melton, R. G., Burke, P. J., Connors, T. A. and Hart, I. R. (1996): Investigation of alternative prodrugs for use with E. coli nitroreductase in’ suicide gene’ approaches to cancer therapy. Gene Therapy 3, 1143–50.

    PubMed  CAS  Google Scholar 

  • Bakker, A. B., Schreurs, M. W., de Boer, A. J., Kawakami, Y., Rosenberg, S. A., Adema, G. J. and Figdor, C. G. (1994): Melanocyte lineage-specific antigen gpl00 is recognized by melanoma-derived tumor-infiltrating lymphocytes. Journal of Experimental Medicine 179, 1005–9.

    PubMed  CAS  Google Scholar 

  • Banchereau, J. and Steinman, R. M. (1998): Dendritic cells and the control of immunity. Nature 392, 245–52.

    Google Scholar 

  • Barnett, B. G., Tillman, B. W., Curiel, D. T. and Douglas, J. T. (2002): Dual targeting of adenoviral vectors at the levels of transduction and transcription enhances the specificity of gene expression in cancer cells. Molecular Ther 6, 377–85.

    CAS  Google Scholar 

  • Becker, C. M., Farnebo, F. A., Iordanescu, I., Behonick, D. J., Shih, M. C, Dunning, P., Christofferson, R., Mulligan, R. C., Taylor, G. A., Kuo, C. J. and Zetter, B. R. (2002): Gene therapy of prostate cancer with the soluble vascular endothelial growth factor receptor flkl. Cancer Biol Ther 1, 548–53.

    PubMed  Google Scholar 

  • Behrend, E. I., Craig, A. M., Wilson, S. M., Denhardt, D. T. and Chambers, A. F. (1995): Expression of antisense osteopontin RNA in metastatic mouse fibroblasts is associated with reduced malignancy. Ann N Y Acad Sci 760, 299–301.

    PubMed  CAS  Google Scholar 

  • Belldegrun, A., Tso, C. L., Zisman, A., Naitoh, J., Said, J., Pantuck, A. J., Hinkel, A., deKernion, J. and Figlin, R. (2001): Interleukin 2 gene therapy for prostate cancer: phase I clinical trial and basic biology. Human Gene Therapy 12, 883–92.

    PubMed  CAS  Google Scholar 

  • Benjamin, R., Helman, L., Meyers, P. and Reaman, G. (2001): A phase I/II dose escalation and activity study of intravenous injections of OCaPl for subjects with refractory osteosarcoma metastatic to lung. Human Gene Therapy 12, 1591–3.

    PubMed  CAS  Google Scholar 

  • Bergelson, J. M., Cunningham, J. A., Droguett, G., Kurt-Jones, E. A., Krithivas, A., Hong, J. S., Horwitz, M. S., Crowell, R. L. and Finberg, R. W. (1997): Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275, 1320–3.

    PubMed  CAS  Google Scholar 

  • Bilbao, G., Feng, M., Rancourt, C., Jackson, W. H., Jr. and Curiel, D. T. (1997): Adenoviral/retroviral vector chimeras: a novel strategy to achieve high-efficiency stable transduction in vivo. Faseb J 11, 624–34.

    PubMed  CAS  Google Scholar 

  • Boczkowski, D., Nair, S. K., Snyder, D. and Gilboa, E. (1996): Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. Journal of Experimental Medicine 184, 465–72.

    PubMed  CAS  Google Scholar 

  • Braithwaite, A. W. and Jenkins, J. R. (1989): Ability of p53 and the adenovirus Elb 58-kilodalton protein to form a complex is determined by p53. Journal of Virology 63, 1792–9.

    PubMed  CAS  Google Scholar 

  • Brown, J. M., Corey, E., Lee, Z. D., True, L. D., Yun, T. J., Tondravi, M. and Vessella, R. L. (2001): Osteoprotegerin and rank ligand expression in prostate cancer. Urology 57, 611–6.

    PubMed  CAS  Google Scholar 

  • Burch, P. A., Breen, J. K., Buckner, J. C., Gastineau, D. A., Kaur, J. A., Laus, R. L., Padley, D.J., Peshwa, M. V., Pitot, H. C, Richardson, R. L., Smits, B. J., Sopapan, P., Strang, G., Valone, F. H. and Vuk-Pavlovic, S. (2000): Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer. Clinical Cancer Research 6, 2175–82.

    PubMed  CAS  Google Scholar 

  • Calmeis, T. P., Mattot, V., Wernert, N., Vandenbunder, B. and Stehelin, D. (1995): Invasive tumors induce c-etsl transcription factor expression in adjacent stroma. Biol Cell 84, 53–61.

    Google Scholar 

  • Camps, J. L., Chang, S. M., Hsu, T. C, Freeman, M. R., Hong, S. J., Zhau, H. E., von Eschenbach, A. C. and Chung, L. W. (1990): Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. Proceedings of the National Acadamy of Sciences USA 87, 75–9.

    Google Scholar 

  • Caplen, N. J., Higginbotham, J. N., Scheel, J. R., Vahanian, N., Yoshida, Y., Hamada, H., Blaese, R. M. and Ramsey, W. J. (1999): Adeno-retroviral chimeric viruses as in vivo transducing agents. Gene Therapy 6, 454–9.

    PubMed  CAS  Google Scholar 

  • Chen, L., Ashe, S., Brady, W. A., Hellstrom, I., Hellstrom, K. E., Ledbetter, J. A., McGowan, P. and Linsley, P. S. (1992): Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71,1093-102.

    Google Scholar 

  • Chen, L., Waxman, D. J., Chen, D. and Kufe, D. W. (1996): Sensitization of human breast cancer cells to cyclophosphamide and ifosfamide by transfer of a liver cytochrome P450 gene. Cancer Research 56, 1331–40.

    PubMed  CAS  Google Scholar 

  • Chen,L., Yu, L. J. and Waxman, D. J. (1997): Potentiation of cytochrome P450/cyclophosphamide-based cancer gene therapy by coexpression of the P450 reductase gene. Cancer Research 57, 4830–7.

    PubMed  CAS  Google Scholar 

  • Chen, S. H., Shine, H. D., Goodman, J. C, Grossman, R. G. and Woo, S. L. (1994): Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proceedings of the National Acadamy of Sciences U S A 91, 3054–7.

    CAS  Google Scholar 

  • Cheon, J., Ko, S. C., Gardner, T. A., Shirakawa, T., Gotoh, A., Kao, C. and Chung, L. W. (1997): Chemogene therapy: osteocalcin promoter-based suicide gene therapy in combination with methotrexate in a murine osteosarcoma model. Cancer Gene Therapy 4, 359–65.

    PubMed  CAS  Google Scholar 

  • Chung, L. W. and Auble, K. (1988): Characterization of fetal urogenital sinus-induced prostatic hyperplasia in the mouse: time course, hormonal requirement, age dependency and responsiveness of various adult organs to growth induction by fetal urogenital sinus tissues. Biol Reprod 39, 50–7.

    PubMed  CAS  Google Scholar 

  • Chung, L. W., Chang, S. M., Bell, C., Zhau, H. E., Ro, J. Y. and von Eschenbach, A. C. (1989): Co-inoculation of tumorigenic rat prostate mesenchymal cells with nontumorigenic epithelial cells results in the development of carcinosarcoma in syngeneic and athymic animals. International Journal of Cancer 43, 1179–87.

    CAS  Google Scholar 

  • Chung, L. W., Kao, C., Sikes, R. A. and Zhau, H. E. (1997): Human prostate cancer progression models and therapeutic intervention. Hinyokika Kiyo 43, 815–20.

    PubMed  CAS  Google Scholar 

  • Chung, L. W., Matsuura, J. and Runner, M. N. (1984): Tissue interactions and prostatic growth. I. Induction of adult mouse prostatic hyperplasia by fetal urogenital sinus implants. Biol Reprod 31, 155–63.

    PubMed  CAS  Google Scholar 

  • Coleman, R. E., Houston, S., James, I., Rodger, A., Rubens, R. D., Leonard, R. C. and Ford, J. (1992): Preliminary results of the use of urinary excretion of pyridinium crosslinks for monitoring metastatic bone disease. British Journal of Cancer 65, 766–8.

    PubMed  CAS  Google Scholar 

  • Conget, P. A. and Minguell, J. J. (2000): Adenoviral-mediated gene transfer into ex vivo expanded human bone marrow mesenchymal progenitor cells. Experimental Hematology 28, 382–90.

    Google Scholar 

  • Cooper, C. R., Chay, C. H. and Pienta, K. J. (2002): The role of alpha(v)beta(3) in prostate cancer progression. Neoplasia 4, 191–4.

    PubMed  CAS  Google Scholar 

  • Cooper, C. R., McLean, L., Walsh, M., Taylor, J., Hayasaka, S., Bhatia, J. and Pienta, K. J. (2000): Preferential adhesion of prostate cancer cells to bone is mediated by binding to bone marrow endothelial cells as compared to extracellular matrix components in vitro. Clinical Cancer Research 6, 4839–47.

    Google Scholar 

  • Corey, E., Brown, L. G., Quinn, J. E., Poot, M., Roudier, M. P., Higano, C. S. and Vessella, R.L. (2003): Zoledronic Acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer. Clinical Cancer Research 9, 295–306.

    PubMed  CAS  Google Scholar 

  • Coussens, L. M. and Werb, Z. (2002): Inflammation and cancer. Nature 420, 860–7.

    PubMed  CAS  Google Scholar 

  • Curatolo, C., Ludovico, G. M., Correale, M., Pagliarulo, A., Abbate, I., Cirrillo Marucco, E. and Barletta, A. (1992): Advanced prostate cancer follow-up with prostate-specific antigen, prostatic acid phosphatase, osteocalcin and bone isoenzyme of alkaline phosphatase. European Urology 21, 105–7.

    PubMed  Google Scholar 

  • Curiel, D. T. (1999): Strategies to adapt adenoviral vectors for targeted delivery. Ann N Y Acad Sci 886, 158–71.

    PubMed  CAS  Google Scholar 

  • Dannull, J., Diener, P. A., Prikler, L., Furstenberger, G., Cerny, T., Schmid, U., Ackermann, D.K. and Groettrup, M. (2000): Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer. Cancer Research 60, 5522–8.

    PubMed  CAS  Google Scholar 

  • Davies, M. A., Kim, S. J., Parikh, N. U., Dong, Z., Bucana, C. D. and Gallick, G. E. (2002): Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells. Clinical Cancer Research 8, 1904–14.

    PubMed  CAS  Google Scholar 

  • Delannoy-Courdent, A., Mattot, V., Fafeur, V., Fauquette, W., Pollet, I., Calmeis, T., Vercamer, C., Boilly, B., Vandenbunder, B. and Desbiens, X. (1998): The expression of an Etsl transcription factor lacking its activation domain decreases uPA proteolytic activity and cell motility and impairs normal tubulogenesis and cancerous scattering in mammary epithelial cells. J Cell Sci 111 ( Pt 11), 1521-34.

    Google Scholar 

  • DeWeese, T. L., van der Poel, H., Li, S., Mikhak, B., Drew, R., Goemann, M., Hamper, U., DeJong, R., Detorie, N., Rodriguez, R., Haulk, T., DeMarzo, A. M., Piantadosi, S., Yu, D. C., Chen, Y., Henderson, D. R., Carducci, M. A., Nelson, W. G. and Simons, J. W. (2001): A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy. Cancer Research 61, 7464–72.

    PubMed  CAS  Google Scholar 

  • Dong, J. Y., Fan, P. D. and Frizzell, R. A. (1996): Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. Human Gene Therapy 7, 2101–12.

    PubMed  CAS  Google Scholar 

  • Dong, Z., Greene, G., Pettaway, C, Dinney, C. P., Eue, I., Lu, W., Bucana, C. D., Balbay, M. D., Bielenberg, D. and Fidler, I. J. (1999): Suppression of angiogenesis, tumorigenicity and metastasis by human prostate cancer cells engineered to produce interferon-beta. Cancer Research 59, 872–9.

    PubMed  CAS  Google Scholar 

  • Eastham, J. A., Chen, S. H., Sehgal, I., Yang, G., Timme, T. L., Hall, S. J., Woo, S. L. and Thompson, T. C. (1996): Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models. Human Gene Therapy 7, 515–23.

    PubMed  CAS  Google Scholar 

  • Eder, J. P., Kantoff, P. W., Roper, K., Xu, G. X., Bubley, G. J., Boyden, J., Gritz, L., Mazzara, G., Oh, W. K., Arlen, P., Tsang, K. Y., Panicali, D., Schlom, J. and Kufe, D. W. (2000): A phase I trial of a recombinant vaccinia virus expressing prostate-specific antigen in advanced prostate cancer. Clinical Cancer Research 6, 1632–8.

    PubMed  CAS  Google Scholar 

  • Edlund, M, Miyamoto, T., Sikes, R. A., Ogle, R., Laurie, G. W., Farach-Carson, M. C., Otey, C. A., Zhau, H. E. and Chung, L. W. (2001): Integrin expression and usage by prostate cancer cell lines on laminin substrata. Cell Growth Differ 12, 99–107.

    PubMed  CAS  Google Scholar 

  • Elenbaas, B. and Weinberg, R. A. (2001): Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Experimental Cell Research 264, 169–84.

    PubMed  CAS  Google Scholar 

  • Elsasser-Beile, U., von Kleist, S., Fischer, R., Martin, M., Wetterauer, U., Gallati, H. and Monting, J. S. (1993): Impaired cytokine production in whole blood cell cultures of patients with urological carcinomas. J Cancer Res Clin Oncol 119, 430–3.

    PubMed  CAS  Google Scholar 

  • Felding-Habermann, B., O’Toole, T. E., Smith, J. W., Fransvea, E., Ruggeri, Z. M., Ginsberg, M. H., Hughes, P. E., Pampori, N., Shattil, S. J., Saven, A. and Mueller, B. M. (2001): Integrin activation controls metastasis in human breast cancer. Proceedings of the National Acadamy of Sciences USA 98, 1853–8.

    CAS  Google Scholar 

  • Feng, M., Jackson, W. H., Jr., Goldman, C. K., Rancourt, C., Wang, M., Dusing, S. K., Siegal, G. and Curiel, D. T. (1997): Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector. Nat Biotechnol 15, 866–70.

    PubMed  CAS  Google Scholar 

  • Folkman, J. (1971): Tumor angiogenesis: therapeutic implications. New England Journal of Medicine 285, 1182–6.

    PubMed  CAS  Google Scholar 

  • Folkman, J. (2001): A new family of mediators of tumor angiogenesis. Cancer Investigation 19, 754–5.

    Google Scholar 

  • Fong, L., Brockstedt, D., Benike, C., Breen, J. K., Strang, G., Ruegg, C. L. and Engleman, E. G. (2001): Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy. Journal of Immunology 167, 7150–6.

    CAS  Google Scholar 

  • Fonseca, M. J., Storm, G., Hennink, W. E., Gerritsen, W. R. and Haisma, H. J. (1999): Cationic polymeric gene delivery of beta-glucuronidase for doxorubicin prodrug therapy. J Gene Med 1,407-14.

    Google Scholar 

  • Franks, L. M. (1956): The spread of prostate cancer. J Pathol Bacteriol 72, 603–11.

    Google Scholar 

  • Franks, L. M., Riddle, P. N., Carbonell, A. W. and Gey, G. O. (1970): A comparative study of the ultrastructure and lack of growth capacity of adult human prostate epithelium mechanically separated from its stroma. Journal of Pathology 100, 113–9.

    PubMed  CAS  Google Scholar 

  • Freytag, S. O., Khil, M., Stricker, H., Peabody, J., Menon, M., DePeralta-Venturina, M., Nafziger, D., Pegg, J., Paielli, D., Brown, S., Barton, K., Lu, M., Aguilar-Cordova, E. and Kim, J. H. (2002): Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer. Cancer Research 62, 4968–76.

    PubMed  CAS  Google Scholar 

  • Friedlos, F., Davies, L., Scanlon, I., Ogilvie, L. M., Martin, J., Stribbling, S. M., Spooner, R. A., Niculescu-Duvaz, I., Marais, R. and Springer, C. J. (2002): Three new prodrugs for suicide gene therapy using carboxypeptidase G2 elicit bystander efficacy in two xenograft models. Cancer Research 62, 1724–9.

    PubMed  CAS  Google Scholar 

  • Gardner, T. A., Ko, S. C., Kao, C., Shirakawa, T., Cheon, J., Gotoh, A., Wu, T. T., Sikes, R. A., Zhau, H. E., Cui, Q., Balian, G. and Chung, L. W. K. (1998): Exploiting stromalepithelial interaction for model development and new strategies of gene therapy for prostate cancer and osteosarcoma metastases. Gene Ther Mol Biol 2, 41–58.

    Google Scholar 

  • Gerber, H. P., McMurtrey, A., Kowalski, J., Yan, M., Keyt, B. A., Dixit, V. and Ferrara, N. (1998): Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3’-kinase/Akt signal transduction pathway. Requirement for Flk1/KDR activation. Journal of Biological Chemistry 273, 30336–43.

    PubMed  CAS  Google Scholar 

  • Gilboa, E., Nair, S. K. and Lyerly, H. K. (1998): Immunotherapy of cancer with dendriticcell-based vaccines. Cancer Immunol Immunother 46, 82–7.

    PubMed  CAS  Google Scholar 

  • Gingrich, J. R., Barrios, R. J., Morton, R. A., Boyce, B. F., DeMayo, F. J., Finegold, M. J., Angelopoulou, R., Rosen, J. M. and Greenberg, N. M. (1996): Metastatic prostate cancer in a transgenic mouse. Cancer Research 56, 4096–102.

    PubMed  CAS  Google Scholar 

  • Glaspy, J. A. (2002): Therapeutic options in the management of renal cell carcinoma. Semin Oncol 29, 41–6.

    PubMed  CAS  Google Scholar 

  • Gleave, M., Hsieh, J. T., Gao, C. A., von Eschenbach, A. C. and Chung, L. W. (1991): Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Research 51, 3753–61.

    PubMed  CAS  Google Scholar 

  • Gleave, M. E., Hsieh, J. T., von Eschenbach, A. C. and Chung, L. W. (1992): Prostate and bone fibroblasts induce human prostate cancer growth in vivo: implications for bidirectional tumor-stromal cell interaction in prostate carcinoma growth and metastasis. Journal of Urology 147, 1151–9.

    PubMed  CAS  Google Scholar 

  • Goldman, C. K., Kendall, R. L., Cabrera, G., Soroceanu, L., Heike, Y., Gillespie, G. Y., Siegal, G. P., Mao, X., Bett, A. J., Huckle, W. R., Thomas, K. A. and Curiel, D. T. (1998): Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis and mortality rate. Proceedings of the National Acadamy of Sciences USA 95, 8795–800.

    CAS  Google Scholar 

  • Goncalves, M. A., van der Velde, I., Janssen, J. M., Maassen, B. T., Heemskerk, E. H., Opstelten, D. J., Knaan-Shanzer, S., Valerio, D. and de Vries, A. A. (2002): Efficient generation and amplification of high-capacity adeno-associated virus/adenovirus hybrid vectors. Journal of Virology 76, 10734–44.

    PubMed  CAS  Google Scholar 

  • Graham, M. C, Scher, H. I., Liu, G. B., Yeh, S. D., Curley, T., Daghighian, F., Goldsmith, S. J. and Larson, S. M. (1999): Rhenium-186-labeled hydroxyethylidene diphosphonate dosimetry and dosing guidelines for the palliation of skeletal metastases from androgenindependent prostate cancer. Clinical Cancer Research 5, 1307–18.

    PubMed  CAS  Google Scholar 

  • Gu, Z., Thomas, G., Yamashiro, J., Shintaku, I. P., Dorey, F., Raitano, A., Witte, O. N., Said, J.W., Loda, M. and Reiter, R. E. (2000): Prostate stem cell antigen (PSCA expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer. Oncogene 19, 1288–96.

    PubMed  CAS  Google Scholar 

  • Guise, T. A., Yin, J. J. and Mohammad, K. S.(2003): Role of endothelin-1 in osteoblastic bone metastases. Cancer 97, 779–84.

    PubMed  Google Scholar 

  • Gulley, J., Chen, A. P., Dahut, W., Arlen, P. M., Bastian, A., Steinberg, S. M., Tsang, K., Panicali, D., Poole, D., Schlom, J. and Michael Hamilton, J. (2002): Phase I study of a vaccine using recombinant vaccinia virus expressing PSA (rV-PSA) in patients with metastatic androgen-independent prostate cancer. Prostate 53, 109–17.

    PubMed  CAS  Google Scholar 

  • Harada, M., Iida, M., Yamaguchi, M. and Shida, K. (1992): Analysis of bone metastasis of prostatic adenocarcinoma in 137 autopsy cases, pp. 137-82. In Kerr and Yamanaka (Eds): Prostate cancer and bone metastasis, Plenum Press, New York.

    Google Scholar 

  • Harui, A., Suzuki, S., Kochanek, S. and Mitani, K. (1999): Frequency and stability of chromosomal integration of adenovirus vectors. Journal of Virology 73, 6141–6.

    PubMed  CAS  Google Scholar 

  • Hayashi, N., Cunha, G. R. and Parker, M. (1993): Permissive and instructive induction of adult rodent prostatic epithelium by heterotypic urogenital sinus mesenchyme. Epithelial Cell Biology 2, 66–78.

    PubMed  CAS  Google Scholar 

  • Healy, C. G., Simons, J. W., Carducci, M. A., DeWeese, T. L., Bartkowski, M., Tong, K. P. and Bolton, W. E. (1998): Impaired expression and function of signal-transducing zeta chains in peripheral T cells and natural killer cells in patients with prostate cancer. Cytometry 32, 109–19.

    Google Scholar 

  • Hedlund, T. E., Duke, R. C., Schleicher, M. S. and Miller, G. J. (1998): Fas-mediated apoptosis in seven human prostate cancer cell lines: correlation with tumor stage. Prostate 36, 92–101.

    PubMed  CAS  Google Scholar 

  • Heidenreich, A., Hofmann, R. and Engelmann, U. H. (2001): The use of bisphosphonate for the palliative treatment of painful bone metastasis due to hormone refractory prostate cancer. Journal of Urology 165, 136–40.

    PubMed  CAS  Google Scholar 

  • Heine, D., Muller, R. and Brusselbach, S. (2001): Cell surface display of a lysosomal enzyme for extracellular gene-directed enzyme prodrug therapy. Gene Therapy 8, 1005–10.

    PubMed  CAS  Google Scholar 

  • Heiser, A., Coleman, D., Dannull, J., Yancey, D., Maurice, M. A., Lallas, C. D., Dahm, P., Niedzwiecki, D., Gilboa, E. and Vieweg, J.(2002): Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors. Journal of Clinical Investigation 109, 409–17.

    PubMed  CAS  Google Scholar 

  • Heiser, A., Dahm, P., Yancey, D. R., Maurice, M. A., Boczkowski, D., Nair, S. K., Gilboa, E. and Vieweg, J. (2000): Human dendritic cells transfected with RNA encoding prostatespecific antigen stimulate prostate-specific CTL responses in vitro. Journal of Immunology 164, 5508–14.

    CAS  Google Scholar 

  • Hitt,M.M. and Gauldie, J.( 2000):Genevectors for cytokine expression in vivo.CurrP harmD es 6,6 13–32.

    CAS  Google Scholar 

  • Hodge,J .W .,S chlom,J .,D onohue,S .J .,T omaszewski,J .E .,W heeler,C .W .,L evine,B .S .,G ritz,L .,P anicali,D .a ndK antor,J .A .( 1995):Arecombinant vaccinia virus expressing human prostate-specific antigen( PSA):safety and immuno genicity in a non-human primate.International Journal of Cancer 63,231–7.

    CAS  Google Scholar 

  • Honn,K.V. and Tang, D.G.( 1992):Adhesion molecules and tumorcell interaction with endothelium and subendothelial matrix.CancerM etastasisR ev 11,3 53–75.

    PubMed  CAS  Google Scholar 

  • Hrouda, D., Baban, B., Dunsmuir, W.D., Kirby, R.S. and Dalgleish, A.G.( 1998):Immuno therapy of advanced prostate cancer: a phase I/II trial using Mycobacterium vaccae(SRL172).British Journal of Urology 82,568–73.

    PubMed  CAS  Google Scholar 

  • Hsieh, C.L., Yang,L., Miao, L., Yeung, F., Kao, C., Yang, H., Zhau, H.E. and Chung, L.W .( 2002):A novel targeting modality to enhance a denoviral replication by vitamin D (3) in androgen-independent human prostate cancer cells and tumors.Cancer Research 62,3 084–92.

    CAS  Google Scholar 

  • Huber, B.E., Austin, E.A., Good, S.S., Knick, V.C, Tibbels,S. and Richards, C.A.( 1993):In vivo anti tumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosin edeaminase.Cancer Research 53,4 619–26.

    CAS  Google Scholar 

  • Huber, B.E., Austin, E.A., Richards, C.A., Davis,S.T. and Good,S.S.( 1994):Metabolism of 5-fluorocytosine to 5-fluorouracilin human colorectal tumor cells transduced with the cytosin edeaminase gene: significant anti tumor effects when only a small percentage of tumor cells express cytosin edeaminase.Proceedings of the National Acadamy of Sciences USA 91,8 302–6.

    CAS  Google Scholar 

  • Hubert,R .S .,V ivanco,I .,C hen,E .,R astegar,S .,L eong,K .,M itchell,S .C .,M adraswala,R .,Z hou,Y .,K uo,J .,R aitano,A .B .,J akobovits,A .,S affran,D .C .a ndA far,D .E .( 1999):S TEAP:a p rostate-specificc ell-surfacea ntigenh ighlye xpressedi nh umanp rostatet umors.Proceedingso ft heN ationalA cadamyo fS ciencesU SA 96,1 4523–8.

    CAS  Google Scholar 

  • Hull,G .W .,M cCurdy,M .A .,N asu,Y .,B angma,C .H .,Y ang,G .,S himura,S .,L ee,H .M .,W ang,J .,A lbani,J .,E bara,S .,S ato,T .,T imme,T .L .a ndT hompson,T .C .( 2000):P rostatec ancerg enet herapy:c omparisono fa denovirus-mediatede xpressiono fi nterleukin1 2w ithi nterleukin1 2p lusB 7-1f ori ns itug enet herapya ndg ene-modified,c ell-basedv accines.ClinicalC ancerR esearch 6,4 101–9.

    CAS  Google Scholar 

  • Hyytinen,E .R .,T halmann,G .N .,Z hau,H .E .,K arhu,R .,K allioniemi,O .P .,C hung,L .W .a ndV isakorpi,T .( 1997):G eneticc hangesa ssociatedw itht hea cquisitiono fa ndrogenindependentg rowth,t umorigenicitya ndm etastaticp otentiali na p rostatec ancerm odel.BritishJ ournalo fC ancer 75,1 90–5.

    CAS  Google Scholar 

  • Ingber,D .E .( 2002):C ancera sa d iseaseo fe pithelial-mesenchymali nteractionsa nde xtracellularm atrixr egulation.Differentiation 70,5 47–60.

    PubMed  Google Scholar 

  • Jackson,M .W .,R oberts,J .S .,H eckford,S .E .,R icciardelli,C .,S tahl,J .,C hoong,C .,H orsfall,D .J .a ndT illey,W .D .( 2002):A p otentiala utocriner olef orv asculare ndothelialg rowthf actori np rostatec ancer.CancerR esearch 62,8 54–9.

    CAS  Google Scholar 

  • Jacob,K .,W ebber,M .,B enayahu,D .a ndK leinman,H .K .( 1999):O steonectinp romotesp rostatec ancerc ellm igrationa ndi nvasion:a p ossiblem echanismf orm etastasist ob one.CancerR esearch 59,4 453–7.

    CAS  Google Scholar 

  • Jemal,A .,M urray,T .,S amuels,A .,G hafoor,A .,W ard,E .a ndT hun,M .J .( 2003):C ancers tatistics,2 003.CAC ancerJ C lin 53,5 –26.

    Google Scholar 

  • Johansson,N .,A honen,M .a ndK ahari,V .M .( 2000):Matrix metalloproteinasesin tumor invasion.Cell Mol Life Sci 57,5 –15.

    PubMed  CAS  Google Scholar 

  • Kanai,F .( 2001):T ranscriptionalt argetedg enet herapyf orh epatocellularc arcinomab ya denovirusv ector.MolecularB iotechnology 18,2 43–50.

    CAS  Google Scholar 

  • Kaplan, J.M., Armentano,D., Sparer, T.E., Wynn, S.G., Peterson, P.A., Wadsworth, S.C., Couture, K.K., Pennington, S.E., St George, J.A., Gooding, L.R. and Smith, A.E.( 1997):Characterization of factors involved in modulating persistence of transgene expression from recombinant adeno virus in the mouse lung.HumanG eneT herapy 8,4 5–56.

    PubMed  CAS  Google Scholar 

  • Kavanaugh,D .Y .a ndC arbone,D .P .( 1996):Immunologic dysfunction in cancer.Hematol Oncol Clin North Am 10,9 27–51.

    PubMed  CAS  Google Scholar 

  • Kawakami,Y .,E liyahu,S .,D elgado,C .H .,R obbins,P .F .,R ivoltini,L .,T opalian,S .L .,M iki,T .a ndR osenberg,S .A .( 1994):C loningo ft heg enec odingf ora s haredh umanm elanomaa ntigenr ecognizedb ya utologousT c ellsi nfiltratingi ntot umor.Proceedingso ft heN ationalA cadamyo fS ciencesU S A 91,3 515–9.

    CAS  Google Scholar 

  • Keck,P .J .,H auser,S .D .,K rivi,G .,S anzo,K .,W arren,T .,F eder,J .a ndC onnolly,D .T .( 1989):V ascularp ermeabilityf actor,a ne ndothelialc ellm itogenr elatedt oP DGF.Science 246,1 309–12.

    PubMed  CAS  Google Scholar 

  • Kerr,J .S .,S iee,A .M .a ndM ousa,S .A .( 2000):S mallm oleculea lpha(v)i ntegrina ntagonists:n ovela nticancera gents.ExpertO pinI nvestigD rugs 9,1 271–9.

    CAS  Google Scholar 

  • Kim,K .J .,L i,B .,W iner,J .,A rmanini,M .,G illett,N .,P hillips,H .S .a ndF errara,N .( 1993):I nhibitiono fv asculare ndothelialg rowthf actor-induceda ngiogenesiss uppressest umourg rowthi nv ivo.Nature 362,8 41–4.

    PubMed  CAS  Google Scholar 

  • Kim,K .R .,Y oshizaki,T .,M iyamori,H .,H asegawa,K .,H orikawa,T .,F urukawa,M .,H arada,S .,S eiki,M .a ndS ato,H .( 2000):T ransformationo fM adin-Darbyc aninek idney( MDCK)e pithelialc ellsb yE pstein-Barrv irusl atentm embranep rotein1 ( LMP1)i nducese xpressiono fE tsla ndi nvasiveg rowth.Oncogene 19,1 764–71.

    PubMed  CAS  Google Scholar 

  • Kitange,G .,K ishikawa,M .,N akayama,T .,N aito,S .,I seki,M .a ndS hibata,S .( 1999a):E xpressiono ft heE ts-1p roto-oncogenec orrelatesw ithm alignantp otentiali nh umana strocytict umors.ModP athol 12,6 18–26.

    CAS  Google Scholar 

  • Kitange,G .,S hibata,S .,T okunaga,Y .,Y agi,N .,Y asunaga,A .,K ishikawa,M .a ndN aito,S .( 1999b):E ts-1t ranscriptionf actor-mediatedu rokinase-typep lasminogena ctivatore xpressiona ndi nvasioni ng liomac ellss timulatedb ys eruma ndb asicf ibroblastg rowthf actors.LaboratoryI nvestigation 79,4 07–16.

    CAS  Google Scholar 

  • Kleeff,J .,F ukahi,K .,L opez,M .E .,F riess,H .,B uchler,M .W .,S osnowski,B .A .a ndK orc,M .( 2002):T argetingo fs uicideg ened eliveryi np ancreaticc ancerc ellsv iaF GFr eceptors.CancerG eneT herapy 9,5 22–32.

    Google Scholar 

  • Ko,S .C .,C heon,J .,K ao,C .,G otoh,A .,S hirakawa,T .,S ikes,R .A .,K arsenty,G .a ndC hung,L .W .( 1996):O steocalcinp romoter-basedt oxicg enet herapyf ort het reatmento fo steosarcomai ne xperimentalm odels.CancerR esearch 56,4 614–9.

    CAS  Google Scholar 

  • Koeneman,K .S .,K ao,C .,K o,S .C .,Y ang,L .,W ada,Y .,K allmes,D .F .,G illenwater,J .Y .,Z hau,H .E .,C hung,L .W .a ndG ardner,T .A .( 2000):O steocalcin-directedg enet herapyf orp rostate-cancerb onem etastasis.WorldJ ournalo fU rology 18,1 02–10.

    CAS  Google Scholar 

  • Koeneman,K .S .,Y eung,F .a ndC hung,L .W .( 1999):O steomimeticp ropertieso fp rostatec ancerc ells:a h ypothesiss upportingt hep redilectiono fp rostatec ancerm etastasisa ndg rowthi nt heb onee nvironment.Prostate 39,2 46–61.

    PubMed  CAS  Google Scholar 

  • Koistinen,P .,P ulli,T .,U itto,V .J .,N issinen,L .,H yypia,T .a ndH eino,J .( 1999):D epletiono fa lphaVi ntegrinsf romo steosarcomac ellsb yi ntracellulara ntibodye xpressioni nducesb oned ifferentiationm arkerg enesa nds uppressesg elatinase( MMP-2)s ynthesis.MatrixB iology 18,2 39–51.

    CAS  Google Scholar 

  • Krasnykh,V .N .,M ikheeva,G .V .,D ouglas,J .T .a ndC uriel,D .T .( 1996):G enerationo fr ecombinanta denovirusv ectorsw ithm odifiedf ibersf ora lteringv iralt ropism.Journalo fV irology 70,6 839–46.

    CAS  Google Scholar 

  • Krummel,M .F .a ndA llison,J .P .( 1995):C D28a ndC TLA-4h aveo pposinge ffectso nt her esponseo fT c ellst os timulation.Journalo fE xperimentalM edicine 182,4 59–65.

    CAS  Google Scholar 

  • Kubo,H .,G ardner,T .A .,W ada,Y .,K oeneman,K .S .,G otoh,A .,Y ang,L .,K ao,C .,L im,S .D .,A min,M .B .,Y ang,H .,B lack,M .E .,M atsubara,S .,N akagawa,M .,G illenwater,J .Y .,Z hau,H .E .a ndC hung,L .W .( 2003):P haseI d osee scalationc linicalt rialo fa denovirusv ectorc arryingo steocalcinp romoter-drivenh erpess implexv irust hymidinek inasei nl ocalizeda ndm etastatich ormone-refractoryp rostatec ancer.HumanG eneT herapy 14,2 27–41.

    CAS  Google Scholar 

  • Kumar,R .a ndF idler,I .J .( 1998):A ngiogenicm oleculesa ndc ancerm etastasis.InV ivo 12,2 7–34.

    CAS  Google Scholar 

  • Kwon,E .D .,F oster,B .A .,H urwitz,A .A .,M adias,C ,A llison,J .P .,G reenberg,N .M .a ndB urg,M .B .( 1999):E liminationo fr esidualm etastaticp rostatec ancera fters urgerya nda djunctivec ytotoxicT l ymphocyte-associateda ntigen4 ( CTLA-4)b lockadei mmunotherapy.Proceedingso ft heN ationalA cadamyo fS ciencesU S A 96,1 5074–9.

    CAS  Google Scholar 

  • Kwon,E .D .,H urwitz,A .A .,F oster,B .A .,M adias,C .,F eldhaus,A .L .,G reenberg,N .M .,B urg,M .B .a ndA llison,J .P .( 1997):M anipulationo fT c ellc ostimulatorya ndi nhibitorys ignalsf ori mmunotherapyo fp rostatec ancer.Proceedingso ft heN ationalA cadamyo fS ciencesU S A 94,8 099–103.

    CAS  Google Scholar 

  • Lapidot,T .a ndK ollet,O .( 2002):T hee ssentialr oleso ft hec hemokineS DF-1a ndi tsr eceptorC XCR4i nh umans temc ellh ominga ndr epopulationo ft ransplantedi mmunedeficientN OD/SCIDa ndN OD/SCID/B2m(null)m ice.Leukemia 16,1 992–2003.

    PubMed  CAS  Google Scholar 

  • Latham,J .P .,S earle,P .F .,M autner,V .a ndJ ames,N .D .( 2000):P rostate-specifica ntigenp romoter/enhancerd riveng enet herapyf orp rostatec ancer:c onstructiona ndt estingo fa t issue-specifica denovirusv ector.CancerR esearch 60,3 34–41.

    CAS  Google Scholar 

  • Lee,C .K .,A eppli,D .M .,U nger,J .,B oudreau,R .J .a ndL evitt,S .H .( 1996):S trontium-89c hloride( Metastron)f orp alliativet reatmento fb onym etastases.T heU niversityo fM innesotae xperience.AmericanJ ournalo fC linicalO ncology 19,1 02–7.

    CAS  Google Scholar 

  • Lee,S .J .,K im,H .S .,Y u,R .,L ee,K .,G ardner,T .A .,J ung,C .,J eng,M .H .,Y eung,F .,C heng,L .a ndK ao,C .( 2002):N ovelp rostate-specificp romoterd erivedf romP SAa ndP SMAe nhancers.MolecularT herapy 6,4 15–21.

    CAS  Google Scholar 

  • Lee,Y .,S chwarz,E .,D avies,M .,J o,M .,G ates,J .,W u,J .,Z hang,X .a ndL ieberman,J .R .( 2003):D ifferencesi nt hec ytokinep rofilesa ssociatedw ithp rostatec ancerc elli nducedo steoblastica ndo steolyticl esionsi nb one.Journalo fO rthopaedicR esearch 21,6 2–72.

    CAS  Google Scholar 

  • Lee,Y .J .,G aloforo,S .S .,B attle,P .,L ee,H .,C orry,P .M .a ndJ essup,J .M .( 2001):R eplicatinga denoviralv ector-mediatedt ransfero fa h eat-inducibled oubles uicideg enef org enet herapy.CancerG eneT herapy 8,3 97–404.

    CAS  Google Scholar 

  • Lenschow,D .J .a ndB luestone,J .A .( 1993):T c ellc o-stimulationa ndi nv ivot olerance.CurrentO pinionsi nI mmunology 5,7 47–52.

    CAS  Google Scholar 

  • Letterio,J .J .a ndR oberts,A .B .( 1998):R egulationo fi mmuner esponsesb yT GF-beta.AnnuR evI mmunol 16,1 37–61.

    CAS  Google Scholar 

  • Li,Y .,P ong,R .C .,B ergelson,J .M .,H all,M .C .,S agalowsky,A .I .,T seng,C .P .,W ang,Z .a ndH sieh,J .T .( 1999):L osso fa denoviralr eceptore xpressioni nh umanb ladderc ancerc ells:a p otentiali mpacto nt hee fficacyo fg enet herapy.CancerR esearch 59,3 25–30.

    CAS  Google Scholar 

  • Liapis,H .,F lath,A .a ndK itazawa,S .( 1996):I ntegrina lphaV b eta3 e xpressionb yb oneresidingb reastc ancerm etastases.DiagnosticM olecularP athology 5,1 27–35.

    CAS  Google Scholar 

  • Lin,D .L .,T arnowski,C .P .,Z hang,J .,D ai,J .,R ohn,E .,P atel,A .H .,M orris,M .D .a ndK eller,E .T .( 2001):B onem etastaticL NCaP-derivativeC 4-2Bp rostatec ancerc elll inem ineralizesi nv itro.Prostate 47,2 12–21.

    PubMed  CAS  Google Scholar 

  • Link,C .J .,J r.,L evy,J .P .,M cCann,L .Z .a ndM oorman,D .W .( 1997):G enet herapyf orc olonc ancerw itht heh erpess implext hymidinek inaseg ene.Journalo fS urgicalO ncology 64,2 89–94.

    CAS  Google Scholar 

  • Linsley,P .S .,G reene,J .L .,B rady,W .,B ajorath,J .,L edbetter,J .A .a ndP each,R .( 1994):H umanB 7-1( CD80)a ndB 7-2( CD86)b indw iths imilara viditiesb utd istinctk ineticst oC D28a ndC TLA-4r eceptors.Immunity 1,7 93–801.

    PubMed  CAS  Google Scholar 

  • Liotta,L .A .a ndK ohn,E .C .( 2001):T hem icroenvironmento ft het umour-hosti nterface.Nature 411,3 75–9.

    PubMed  CAS  Google Scholar 

  • Lissbrant,I .F .,S tattin,P .,D amber,J .E .a ndB ergh,A .( 1997):V asculard ensityi sa p redictoro fc ancer-specifics urvivali np rostaticc arcinoma.Prostate 33,3 8–45.

    PubMed  CAS  Google Scholar 

  • Liu,Q .Y .,R ubin,M .A .,O mene,C .,L ederman,S .a ndS tein,C .A .( 1998):F asl igandi sc onstitutivelys ecretedb yp rostatec ancerc ellsi nv itro.ClinicalC ancerR esearch 4,1 803–11.

    CAS  Google Scholar 

  • Mailliard,R .B .a ndL otze,M .T .( 2001):D endriticc ellsp rolongt umor-specificT -cells urvivala nde ffectorf unctiona fteri nteractionw itht umort argets.ClinicalC ancerR esearch 7,9 80s–988s.

    CAS  Google Scholar 

  • Matsubara,S .,W ada,Y .,G ardner,T .A .,E gawa,M .,P ark,M .S .,H sieh,C .L .,Z hau,H .E .,K ao,C .,K amidono,S .,G illenwater,J .Y .a ndC hung,L .W .( 2001):A c onditionalr eplication-competenta denoviralv ector,A d-OC-Ela,t oc otargetp rostatec ancera ndb ones tromai na ne xperimentalm odelo fa ndrogen-independentp rostatec ancerb onem etastasis.CancerR esearch 61,6 012–9.

    CAS  Google Scholar 

  • McNeal,J .( 1990):P athologyo fb enignp rostatich yperplasia.I nsighti ntoe tiology.UrolC linN orthA m 17,4 77–86.

    CAS  Google Scholar 

  • Miles,B .J .,S halev,M .,A guilar-Cordova,E .,T imme,T .L .,L ee,H .M .,Y ang,G .,A dler,H .L .,K ernen,K .,P ramudji,C .K .,S atoh,T .,G dor,Y .,R en,C .,A yala,G .,W heeler,T .M .,B utler,E .B .,K admon,D .a ndT hompson,T .C .( 2001):P rostate-specifica ntigenr esponsea nds ystemicT c ella ctivationa fteri ns itug enet herapyi np rostatec ancerp atientsf ailingr adiotherapy.HumanG eneT herapy 12,1 955–67.

    CAS  Google Scholar 

  • Millauer,B .,L onghi,M .P .,P late,K .H .,S hawver,L .K .,R isau,W .,U llrich,A .a ndS trawn,L .M.( 1996):D ominant-negativei nhibitiono fF lk-1s uppressest heg rowtho fm anyt umort ypesi nv ivo.CancerR esearch 56,1 615–20.

    CAS  Google Scholar 

  • Miller,G .J .,R unner,M .N .a ndC hung,L .W .( 1985):Tissue interactions and prostatic growth: II. Morphological and biochemical characterization of adult mouse prostatic hyperplasia induced by fetaluro genital sinus implants.Prostate 6,2 41–53.

    PubMed  CAS  Google Scholar 

  • Mintz,E .R .a ndS mith,G .G .( 1934):Autopsy findings in 100 cases of prostate cancer.New England Journal of Medicine 211,4 79–87.

    Google Scholar 

  • Mitani,K .,G raham,F .L .,C askey,C .T .a ndK ochanek,S .( 1995):R escue,p ropagationa ndp artialp urificationo fa h elperv irus-dependenta denovirusv ector.Proceedingso ft heN ationalA cadamyo fS ciencesU SA 92,3 854–8.

    CAS  Google Scholar 

  • Miyagi,T .,H ori,O .,K oshida,K .,E gawa,M .,K ato,H .,K itagawa,Y .,O zawa,K .,O gawa,S .a ndN amiki,M .( 2002):A ntitumore ffecto fr eductiono f1 50-kDao xygen-regulatedp roteine xpressiono nh umanp rostatec ancerc ells.InternationalJ ournalo fU rology 9,5 77–85.

    CAS  Google Scholar 

  • Mocellin,S .,W ang,E .a ndM arincola,F .M .( 2001):C ytokinesa ndi mmuner esponsei nt het umorm icroenvironment.Journalo fI mmunotherapy 24,3 92–407.

    CAS  Google Scholar 

  • Monsky,W .L .,M outaC arreira,C .,T suzuki,Y .,G ohongi,T .,F ukumura,D .a ndJ ain,R .K .( 2002):R oleo fh ostm icroenvironmenti na ngiogenesisa ndm icrov ascularf unctionsi nh umanb reastc ancerx enografts:m ammaryf atp adv ersusc ranialt umors.ClinicalC ancerR esearch 8,1 008–13.

    CAS  Google Scholar 

  • Morsy,M .A .a ndC askey,C .T .( 1999):E xpanded-capacitya denoviralv ectors-theh elperdependentv ectors.MolM edT oday 5,1 8–24.

    CAS  Google Scholar 

  • Muller,A .,H omey,B .,S oto,H .,G e,N .,C atron,D .,B uchanan,M .E .,M cClanahan,T .,M urphy,E .,Y uan,W .,W agner,S .N .,B arrera,J .L .,M ohar,A .,V erastegui,E .a ndZ lotnik,A .( 2001):I nvolvemento fc hemokiner eceptorsi nb reastc ancerm etastasis.Nature 410,5 0–6.

    PubMed  CAS  Google Scholar 

  • Mundy,G .R .( 1997):M echanismso fb onem etastasis.Cancer 80,1 546–56.

    PubMed  CAS  Google Scholar 

  • Murakami,T .,M aki,W .,C ardones,A .R .,F ang,H .,T unK yi,A .,N estle,F .O .a ndH wang,S .T.( 2002):E xpressiono fC XCc hemokiner eceptor-4e nhancest hep ulmonarym etastaticp otentialo fm urineB 16m elanomac ells.CancerR esearch 62,7 328–34.

    CAS  Google Scholar 

  • Murphy,G .,T joa,B .,R agde,H .,K enny,G .a ndB oynton,A .( 1996):P haseI c linicalt rial:T -cellt herapyf orp rostatec anceru singa utologousd endriticc ellsp ulsedw ithH LA-A0201-specificp eptidesf romp rostate-specificm embranea ntigen.Prostate 29,3 71–80.

    PubMed  CAS  Google Scholar 

  • Naito,S .,S himizu,K .,N akashima,M .,N akayama,T .,I to,T .,I to,M .,Y amashita,S .a ndS ekine,I .( 2000):O verexpressiono fE ts-1t ranscriptionf actori na ngiosarcomao ft hes kin.PatholR esP ract 196,1 03–9.

    CAS  Google Scholar 

  • Nakayama,T .,I to,M .,O htsuru,A .,N aito,S .,N akashima,M .,F agin,J .A .,Y amashita,S .a ndS ekine,I .( 1996):E xpressiono ft heE ts-1p roto-oncogenei nh umang astricc arcinoma:c orrelationw itht umori nvasion.AmericanJ ournalo fP athology 149,1 931–9.

    CAS  Google Scholar 

  • Nakayama,T .,I to,M .,O htsuru,A .,N aito,S .a ndS ekine,I .( 2001):E xpressiono ft hee ts-1p roto-oncogenei nh umanc olorectalc arcinoma.ModP athol 14,4 15–22.

    CAS  Google Scholar 

  • Nasu,Y .,B angma,C .H .,H ull,G .W .,L ee,H .M ,H u,J .,W ang,J .,M cCurdy,M .A .,S himura,S .,Y ang,G .,T imme,T .L .a ndT hompson,T .C .(1999):A denovirus-mediatedi nterleukin-12g enet herapyf orp rostatec ancer:s uppressiono fo rthotopict umorg rowtha ndp re-establishedl ungm etastasesi na no rthotopicm odel.GeneT herapy 6,3 38–49.

    CAS  Google Scholar 

  • Navone,N .M .,T roncoso,P .,P isters,L .L .,G oodrow,T .L .,P almer,J .L .,N ichols,W .W .,v onE schenbach,A .C .a ndC onti,C .J .( 1993):p 53p roteina ccumulationa ndg enem utationi nt hep rogressiono fh umanp rostatec arcinoma.Journalo ft heN ationalC ancerI nstitute 85,1 657–69.

    CAS  Google Scholar 

  • Nelson,J .B .,N guyen,S .H .,W u-Wong,J .R .,O pgenorth,T .J .,D ixon,D .B .,C hung,L .W .a ndI noue,N .( 1999a):N ewb onef ormationi na no steoblastict umorm odeli si ncreasedb ye ndothelin-1o verexpressiona ndd ecreasedb ye ndothelinA r eceptorb lockade.Urology 53,1 063–9.

    PubMed  CAS  Google Scholar 

  • Nelson,P .S .,G an,L .,F erguson,C .,M oss,P .,G elinas,R .,H ood,L .a ndW ang,K .( 1999b):M olecularc loninga ndc haracterizationo fp rostase,a na ndrogen-regulateds erinep roteasew ithp rostate-restrictede xpression.Proceedingso ft heN ationalA cadamyo fS ciencesU SA 96,3 114–9.

    CAS  Google Scholar 

  • Nemeth, J.A., Yousif, R., Herzog, M., Che, M., Upadhyay, J., Shekarriz, B., Bhagat, S., Mullins, C., Fridman,R. and Cher,M .L .( 2002):Matrix metalloproteinase activity, bone matrix turn over and tumor cell proliferation in prostate cancer bone metastasis.Journal of the National Cancer Institute 94,1 7–25.

    PubMed  CAS  Google Scholar 

  • Nettelbeck,D .M .,J erome,V .a ndM uller,R .( 2000):G enet herapy:d esignerp romotersf ort umourt argeting.TrendsG enet 16,1 74–81.

    CAS  Google Scholar 

  • Nishihara,E .,N agayama,Y .,M awatari,F .,T anaka,K .,N amba,H .,N iwa,M .a ndY amashita,S .( 1997):R etrovirus-mediatedh erpess implexv irust hymidinek inaseg enet ransductionr endersh umant hyroidc arcinomac elll iness ensitivet og anciclovira ndr adiationi nv itroa ndi nv ivo.Endocrinology 138,4 577–83.

    PubMed  CAS  Google Scholar 

  • Nishizaki,M .,F ujiwara,T .,T anida,T .,H izuta,A .,N ishimori,H .,T okino,T .,N akamura,Y .,B ouvet,M .,R oth,J .A .a ndT anaka,N .( 1999):R ecombinanta denoviruse xpressingw ildtypep 53i sa ntiangiogenic:a p roposedm echanismf orb ystandere ffect.ClinicalC ancerR esearch 5,1 015–23.

    CAS  Google Scholar 

  • Nossal,G .J .( 1994):N egatives electiono fl ymphocytes.Cell 76,2 29–39.

    PubMed  CAS  Google Scholar 

  • Oettgen,P .,F inger,E .,S un,Z .,A kbarali,Y .,T hamrongsak,U .,B oltax,J .,G rall,F .,D ube,A .,W eiss,A .,B rown,L .,Q uinn,G .,K as,K .,E ndress,G .,K unsch,C .a ndL ibermann,T .A .( 2000):P DEF,a n ovelp rostatee pithelium-specifice tst ranscriptionf actor,i nteractsw itht hea ndrogenr eceptora nda ctivatesp rostate-specifica ntigeng enee xpression.Journalo fB iologicalC hemistry 275,1 216–25.

    CAS  Google Scholar 

  • Okegawa,T .,L i,Y .,P ong,R .C .,B ergelson,J .M .,Z hou,J .a ndH sieh,J .T .( 2000):T hed uali mpacto fc oxsackiea nda denovirusr eceptore xpressiono nh umanp rostatec ancerg enet herapy.CancerR esearch 60,5 031–6.

    CAS  Google Scholar 

  • Olumi,A .F .,D azin,P .a ndT lsty,T .D .( 1998):A n ovelc oculturet echniqued emonstratest hatn ormalh umanp rostaticf ibroblastsc ontributet ot umorf ormationo fL NCaPc ellsb yr etardingc elld eath.CancerR esearch 58,4 525–30.

    CAS  Google Scholar 

  • Olumi,A .F .,G rossfeld,G .D .,H ayward,S .W .,C arroll,P .R .,T lsty,T .D .a ndC unha,G .R .( 1999):C arcinoma-associatedf ibroblastsd irectt umorp rogressiono fi nitiatedh umanp rostatice pithelium.CancerR esearch 59,5 002–11.

    CAS  Google Scholar 

  • Ozaki,I .,M izuta,T .,Z hao,G .,Y otsumoto,H .,H ara,T .,K ajihara,S .,H isatomi,A .,S akai,T .a ndY amamoto,K .( 2000):I nvolvemento ft heE ts-1g enei no verexpressiono fm atrilysini nh umanh epatocellularc arcinoma.CancerR esearch 60,6 519–25.

    CAS  Google Scholar 

  • Pantuck,A .J .,Z isman,A .a ndB elldegrun,A .S .( 2000):G enet herapyf orp rostatec ancera tt heU niversityo fC alifornia,L osA ngeles:p reliminaryr esultsa ndf utured irections.WorldJ ournalo fU rology 18,1 43–7.

    CAS  Google Scholar 

  • Pantuck,A .J .,Z isman,A .,H enderson,D .,W ilson,D .,S chreiber,A .a ndB elldegrun,A .( 2001):N ewb iologicalsf orp rostatec ancerp revention:G enes,v accinesa ndi mmunebasedi nterventions.Urology 57,9 5–9.

    PubMed  CAS  Google Scholar 

  • Papapoulos,S .E .,H amdy,N .A .a ndv and erP luijm,G .( 2000):B isphosphonatesi nt hem anagemento fp rostatec arcinomam etastatict ot hes keleton.Cancer 88,3 047–53.

    PubMed  CAS  Google Scholar 

  • Parkinson,R .J .,M ian,S .,B ishop,M .C .,G ray,T .,L i,G .,M cArdle,S .E .,A li,S .a ndR ees,R .C .( 2003):D isabledi nfectiouss inglec ycleh erpess implexv irus( DISC-HSV)i sa c andidatev ectors ystemf org ened elivery/expressiono fG M-CSFi nh umanp rostatec ancert herapy.Prostate 56,6 5–73.

    PubMed  CAS  Google Scholar 

  • Parmiani,G .,C astelli,C .,D alerba,P .,M ortarini,R .,R ivoltini,L .,M arincola,F .M .a ndA nichini,A .( 2002):C anceri mmunotherapyw ithp eptide-basedv accines:w hath avew ea chieved?W herea rew eg oing?Journalo ft heN ationalC ancerI nstitute 94,8 05–18.

    CAS  Google Scholar 

  • Pathak,S .,N emeth,M .A .,M ultani,A .S .,T halmann,G .N .,v onE schenbach,A .C .a ndC hung,L .W .( 1997):C anc ancerc ellst ransformn ormalh ostc ellsi ntom alignantc ells?BritishJ ournalo fC ancer 76,1 134–8.

    CAS  Google Scholar 

  • PistersL L,M .T .,T roncosoP ,B risbayS ,H ossanE ,P ettawayC ,W oodC ,E vansR ,S teinerM ,M errittJ ,L ogothetisC .( 2001):I ntraprostaticA d-p53g enet herapyi nducesa poptosisi nl ocallya dvanceda denocarcinomao ft hep rostate.Proceedingso ft heA mericanS ocietyo fC linicalO ncology,p p.1 75a[ abstract6 99].

    Google Scholar 

  • Quaranta,V .( 2002):M otilityc uesi nt het umorm icroenvironment.D ifferentiation70,5 90–8.

    PubMed  Google Scholar 

  • Reiter,R .E .,G u,Z .,W atabe,T .,T homas,G .,S zigeti,K .,D avis,E .,W ahl,M .,N isitani,S .,Y amashiro,J .,L eB eau,M .M .,L oda,M .a ndW itte,O .N .( 1998):P rostates temc ella ntigen:a c ells urfacem arkero verexpressedi np rostatec ancer.Proceedingso ft heN ationalA cadamyo fS ciencesU SA 95,1 735–40.

    CAS  Google Scholar 

  • Ren,C .,L i,L .,G oltsov,A .A .,T imme,T .L .,T ahir,S .A .,W ang,J .,G arza,L .,C hinault,A .C .a ndT hompson,T .C .( 2002):m RTVP-1,a n ovelp 53t argetg enew ithp roapoptotica ctivities.MolecularC ellularB iology 22,3 345–57.

    CAS  Google Scholar 

  • Rhee,H .W .,Z hau,H .E .,P athak,S .,M ultani,A .S .,P ennanen,S .,V isakorpi,T .a ndC hung,L .W .( 2001):P ermanentp henotypica ndg enotypicc hangeso fp rostatec ancerc ellsc ulturedi na t hree-dimensionalr otating-wallv essel.InV itroC ellD evB iolA nim 37,1 27–40.

    CAS  Google Scholar 

  • Rich,T .,C hen,P .,F urman,F .,H uynh,N .a ndI srael,M .A .( 1996):R TVP-1,a n ovelh umang enew iths equences imilarityt og eneso fd iverses pecies,i se xpressedi nt umorc elll ineso fg lialb utn otn euronalo rigin.Gene 180,1 25–30.

    PubMed  CAS  Google Scholar 

  • Rodriguez,R .,S chuur,E .R .,L im,H .Y .,H enderson,G .A .,S imons,J .W .a ndH enderson,D .R .( 1997):P rostatea ttenuatedr eplicationc ompetenta denovirus( ARCA)C N706:a s electivec ytotoxicf orp rostate-specifica ntigen-positivep rostatec ancerc ells.CancerR esearch 57,2 559–63.

    CAS  Google Scholar 

  • Rogulski,K .R .,W ing,M .S .,P aielli,D .L .,G ilbert,J .D .,K im,J .H .a ndF reytag,S .O .( 2000):D oubles uicideg enet herapya ugmentst hea ntitumora ctivityo fa r eplicationcompetentl ytica denovirust hroughe nhancedc ytotoxicitya ndr adiosensitization.HumanG eneT herapy 11,6 7–76.

    CAS  Google Scholar 

  • Roland,S .( 1958):C alsiums tudiesi nt enc aseso fo st4eoblastip rostaticm etastasis.Journalo fU rology 79,3 39–42.

    CAS  Google Scholar 

  • Ronnov-Jessen,L .,P etersen,O .W .,K oteliansky,V .E .a ndB issell,M .J .( 1995):T heo rigino ft hem yofibroblastsi nb reastc ancer.R ecapitulationo ft umore nvironmenti nc ultureu nravelsd iversitya ndi mplicatesc onvertedf ibroblastsa ndr ecruiteds moothm usclec ells.Journalo fC linicalI nvestigation 95,8 59–73.

    CAS  Google Scholar 

  • Rosolen,A .,F rascella,E .,d iF rancesco,C .,T odesco,A .,P etrone,M .,M ehtali,M .,Z acchello,F .,Z anesco,L .a ndS carpa,M .( 1998):I nv itroa ndi nv ivoa ntitumore ffectso fr etrov irusmediatedh erpess implext hymidinek inaseg ene-transferi nh umanm edulloblastoma.GeneT her5,1 13–20.

    CAS  Google Scholar 

  • Ross,S .,S pencer,S .D .,H olcomb,I .,T an,C ,H ongo,J .,D evaux,B .,R angell,L .,K eller,G .A .,S chow,P .,S teeves,R .M .,L utz,R .J .,F rantz,G .,H illan,K .,P eale,F .,T obin,P .,E berhard,D .,R ubin,M .A .,L asky,L .A .a ndK oeppen,H .( 2002):P rostates temc ella ntigena st herapyt arget:t issuee xpressiona ndi nv ivoe fficacyo fa ni mmunoconjugate.CancerR esearch 62,2 546–53.

    CAS  Google Scholar 

  • Saffran,D .G ,R aitano,A .B .,H ubert,R .S .,W itte,O .N .,R eiter,R .E .a ndJ akobovits,A .( 2001):A nti-PSCAm Absi nhibitt umorg rowtha ndm etastasisf ormationa ndp rolongt hes urvivalo fm iceb earingh umanp rostatec ancerx enografts.Proceedingso ft heN ationalA cadamyo fS ciencesU SA 98,2 658–63.

    CAS  Google Scholar 

  • Salgaller,M .L .,L odge,P .A .,M cLean,J .G .,T joa,B .A .,L oftus,D .J .,R agde,H .,K enny,G .M .,R ogers,M .,B oynton,A .L .a ndM urphy,G .P .( 1998a):R eporto fi mmunem onitoringo fp rostatec ancerp atientsu ndergoingT -cellt herapyu singd endriticc ellsp ulsedw ithH LA-A2-specificp eptidesf romp rostate-specificm embranea ntigen( PSMA.Prostate 35,1 44–51.

    PubMed  CAS  Google Scholar 

  • Salgaller,M .L .,T joa,B .A .,L odge,P .A .,R agde,H .,K enny,G .,B oynton,A .a ndM urphy,G .P .( 1998b):D endriticc ell-basedi mmunotherapyo fp rostatec ancer.CritR evI mmunol 18,1 09–19.

    CAS  Google Scholar 

  • Sanda,M .G .,A yyagari,S .R .,J affee,E .M .,E pstein,J .I .,C lift,S .L .,C ohen,L .K .,D ranoff,G .,P ardoll,D .M .,M ulligan,R .C .a ndS imons,J .W .( 1994):D emonstrationo fa r ationals trategyf orh umanp rostatec ancerg enet herapy.Journalo fU rology 151,6 22–8.

    CAS  Google Scholar 

  • Sanda,M .G .,S mith,D .C .,C harles,L .G .,H wang,C ,P ienta,K .J .,S chlom,J .,M ilenic,D .,P anicali,D .a ndM ontie,J .E .( 1999):R ecombinantv accinia-PSA( PROSTVAC)c ani nducea p rostate-specifici mmuner esponsei na ndrogen-modulatedh umanp rostatec ancer.Urology 53,2 60–6.

    PubMed  CAS  Google Scholar 

  • Satoh,T .,T imme,T .L .,S aika,T .,E bara,S .,Y ang,G .,W ang,J .,R en,G ,K usaka,N .,M ouraviev,V .a ndT hompson,T .C .( 2003):A denoviralV ector-Mediatedm RTVP-1G eneT herapyf orP rostateC ancer.HumanG eneT herapy 14,9 1–101.

    CAS  Google Scholar 

  • Schoggins,J .W .,G all,J .G .a ndF alck-Pedersen,E .( 2003):S ubgroupB a ndf f iberc himerase liminaten ormala denovirust ype5 v ectort ransductioni nv itroa ndi nv ivo.Journalo fV irology 77,1 039–48.

    CAS  Google Scholar 

  • Sementchenko,V .I .a ndW atson,D .K .( 2000):E tst argetg enes:p ast,p resenta ndf uture.Oncogene 19,6 533–48.

    PubMed  CAS  Google Scholar 

  • Shah,A .H .,T abayoyong,W .B .,K undu,S .D .,K im,S .J .,V anP arijs,L .,L iu,V .C .,K won,E .,G reenberg,N .M .a ndL ee,C .( 2002):S uppressiono ft umorm etastasisb yb lockadeo ft ransformingg rowthf actorb etas ignalingi nb onem arrowc ellst hrougha r etroviralmediatedg enet herapyi nm ice.CancerR esearch 62,7 135–8.

    CAS  Google Scholar 

  • Shao,R .,X ia,W .a ndH ung,M .C .( 2000):I nhibitiono fa ngiogenesisa ndi nductiono fa poptosisa rei nvolvedi nE lA-mediatedb ystandere ffecta ndt umors uppression.CancerR esearch 60,3 123–6.

    CAS  Google Scholar 

  • Shekhar,M .P .,P auley,R .a ndH eppner,G .( 2003):H ostm icroenvironmenti nb reastc ancerd evelopment:e xtracellularm atrix-stromalc ellc ontributiont on eoplasticp henotypeo fe pithelialc ellsi nt heb reast.BreastC ancerR esearch 5,1 30–5.

    CAS  Google Scholar 

  • Shirakawa,T .,K o,S .C .,G ardner,T .A .,C heon,J .,M iyamoto,T .,G otoh,A .,C hung,L .W .a ndK ao,C .( 1998):I nv ivos uppressiono fo steosarcomap ulmonarym etastasisw ithi ntravenouso steocalcinp romoter-basedt oxicg enet herapy.CancerG eneT herapy 5,2 74–80.

    CAS  Google Scholar 

  • Siemens,D .R .,A ustin,J .C .,H edican,S .P .,T artaglia,J .a ndR atliff,T .L .( 2000):V iralv ectord eliveryi ns olid-statev ehicles:g enee xpressioni na m urinep rostatec ancerm odel.Journalo ft heN ationalC ancerI nstitute 92,4 03–12.

    Google Scholar 

  • Simons,J .W .a ndM ikhak,B .( 1998):E x-vivog enet herapyu singc ytokine-transducedt umorv accines:m oleculara ndc linicalp harmacology.SeminO ncol 25,6 61–76.

    CAS  Google Scholar 

  • Simons,J .W .,M ikhak,B .,C hang,J .F .,D eMarzo,A .M .,C arducci,M .A .,L im,M .,W eber,C .E .,B accala,A .A .,G oemann,M .A .,C lift,S .M .a ndo,D .G .,L evitsky,H .I .,C ohen,L .K .,S anda,M .G .,M ulligan,R .C .,P artin,A .W .,C arter,H .B .,P iantadosi,S .,M arshall,F .F .a ndN elson,W .G .( 1999):I nductiono fi mmunityt op rostatec ancera ntigens:r esultso fa c linicalt rialo fv accinationw ithi rradiateda utologousp rostatet umorc ellse ngineeredt os ecreteg ranulocyte-macrophagec olony-stimulatingf actoru singe xv ivog enet ransfer.CancerR esearch 59,5 160–8.

    CAS  Google Scholar 

  • Singh,S .,B arrett,J .,S akata,K .,T ozer,R .G.a ndS ingh,G .( 2002):E TSp roteinsa ndM MPs:p artnersi ni nvasiona ndm etastasis.CurrD rugT argets 3,3 59–67.

    CAS  Google Scholar 

  • Sotomayor,E .M .,B orrello,I .a ndL evitsky,H .I .( 1996):T olerancea ndc ancer:a c riticali ssuei nt umori mmunology.CritR evO ncog 7,4 33–56.

    CAS  Google Scholar 

  • Stearns,M .E .,G arcia,F .U .,F udge,K .,R him,J .a ndW ang,M .( 1999):Role of inter leukin 10 and transforming growth factor betalin the angio genesis and metastasis of human prostate primary tumor lines from orthotopicim plantsin severe combined immuno deficiency mice.ClinicalC ancerR esearch 5,7 11–20.

    CAS  Google Scholar 

  • Steiner,M .S .,Z hang,X .,W ang,Y .a ndL u,Y .( 2000):G rowthi nhibitiono fp rostatec ancerb ya na denoviruse xpressinga n ovelt umors uppressorg ene,p Hyde.CancerR esearch 60,4 419–25.

    CAS  Google Scholar 

  • Stephenson,J .( 2001):E xperimentalp rostatec ancerd rugss lowd iseasep rogression.Journalo ft heA mericanM edicalA ssociation 286,3 4.

    CAS  Google Scholar 

  • Stribbling,S .M .,F riedlos,F .,M artin,J .,D avies,L .,S pooner,R .A .,M arais,R .a ndS pringer,C .J .( 2000):R egressionso fe stablishedb reastc arcinomax enograftsb yc arboxypeptidaseG 2s uicideg enet herapya ndt hep rodrugC MDAa red uet oa b ystandere ffect.HumanG eneT herapy 11,2 85–92.

    CAS  Google Scholar 

  • Su,L .,M ukherjee,A .B .a ndM ukherjee,B .B .( 1995):E xpressiono fa ntisenseo steopontinR NAi nhibitst umorp romoter-inducedn eoplastict ransformationo fm ouseJ B6e pidermalc ells.Oncogene 10,2 163–9.

    PubMed  CAS  Google Scholar 

  • Sung,S .Y .a ndC hung,L .W .( 2002):P rostatet umor-stromai nteraction:m olecularm echanismsa ndo pportunitiesf ort herapeutict argeting.Differentiation 70,5 06–21.

    PubMed  CAS  Google Scholar 

  • Sweeney,P .,K arashima,T .,K im,S .J .,K edar,D .,M ian,B .,H uang,S .,B aker,C .,F an,Z .,H icklin,D .J .,P ettaway,C .A .a ndD inney,C .P .( 2002):Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metallo proteinase type 9 production.Clinical Cancer Research 8,2 714–24.

    PubMed  CAS  Google Scholar 

  • Szostak,M .J .a ndK yprianou,N .( 2000):R adiation-induceda poptosis:p redictivea ndt herapeutics ignificancei nr adiotherapyo fp rostatec ancer( review).Oncology Report 7,6 99–706.

    CAS  Google Scholar 

  • Taichman,R .S .,C ooper,C .,K eller,E .T .,P ienta,K .J .,T aichman,N .S .a ndM cCauley,L .K .( 2002):U seo ft hes tromalc ell-derivedf actor-1/CXCR4p athwayi np rostatec ancerm etastasist ob one.CancerR esearch 62,1 832–7.

    CAS  Google Scholar 

  • Thalmann,G .N .,A nezinis,P .E .,C hang,S .M .,Z hau,H .E .,K im,E .E .,H opwood,V .L .,P athak,S .,v onE schenbach,A .C .a ndC hung,L .W .( 1994):Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer.Cancer Research 54,2 577–2581.

    PubMed  CAS  Google Scholar 

  • Thalmann,G.N., Sikes, R.A., Devoll, R.E., Kiefer, J.A., Markwalder, R., Klima, I., Farach Carson,C.M., Studer, U.E. and Chung, L.W .( 1999):Osteopontin: possible role in cancer progression.Clincial Cancer Research 52271–2277.

    CAS  Google Scholar 

  • Thalmann, G .N .,S ikes,R .A .,W u,T .T .,D egeorges,A .,C hang,S .M .,O zen,M .,P athak,S .a ndC hung,L .W .( 2000):LNCaP progression model of human prostate cancer: and rogen independence and osseous metastasis.Prostate 44,9 1–103J ul1 ;44(2).

    PubMed  CAS  Google Scholar 

  • Tjoa,B .A .,E rickson,S .J .,B owes,V .A .,R agde,H .,K enny,G .M .,C obb,O .E .,I reton,R .C ,T roychak,M .J .,B oynton,A .L .a ndM urphy,G .P .( 1997):F ollow-upe valuationo fp rostatec ancerp atientsi nfusedw itha utologousd endriticc ellsp ulsedw ithP SMAp eptides.Prostate 32,2 72–8.

    PubMed  CAS  Google Scholar 

  • Tjoa,B .A .,S immons,S .J .,B owes,V .A .,R agde,H .,R ogers,M .,E lgamal,A .,K enny,G .M .,C obb,O .E .,I reton,R .C .,T roychak,M .J .,S algaller,M .L .,B oynton,A .L .a ndM urphy,G .P .( 1998):E valuationo fp haseI /IIc linicalt rialsi np rostatec ancerw ithd endriticc ellsa ndP SMAp eptides.Prostate 36,3 9–44.

    PubMed  CAS  Google Scholar 

  • Tjoa,B .A .,Simmons,S .J ., Elgamal, A ,Rogers, M., Ragde, H., Kenny, G.M., Troychak, M.J., Boynton, A .L. and Murphy, G .P.( 1999):Follow-up evaluation of a phase II prostate cancer vaccine trial.Prostate 40, 125–129.

    PubMed  CAS  Google Scholar 

  • Tomko,R .P .,X u,R .a ndP hilipson,L .( 1997):H CARa ndM CAR:t heh umana ndm ousec ellularr eceptorsf ors ubgroupC a denovirusesa ndg roupB c oxsackieviruses.Proceedingso ft heN ationalA cadamyo fS ciencesU S A 94,3 352–6.

    CAS  Google Scholar 

  • Topf, N., Worgall, S., Hackett, N. R. and Crystal, R.G.( 1998):Regional‘pro-drug’gene therapy: intravenous administration of an adenoviral vector expressing the E.coli cytosin edeaminase gene and systemic administration of 5-fluorocytosine suppresses growth of hepatic metastasis of colon carcinoma.GeneT herapy 5,5 07–13.

    CAS  Google Scholar 

  • Torrent,C .,J ullien,C .,K latzmann,D .,P erricaudet,M .a ndY eh,P .( 2000):T ransgenea mplificationa ndp ersistencea fterd eliveryo fr etroviralv ectora ndp ackagingf unctionsw ithE l/E4-deleteda denoviruses.CancerG eneT herapy 7,1 135–44.

    CAS  Google Scholar 

  • Townsend,S .E .a ndA llison,J .P .( 1993):T umorr ejectiona fterd irectc ostimulationo fC D8+T c ellsb yB 7-transfectedm elanomac ells.Science 259,3 68–70.

    PubMed  CAS  Google Scholar 

  • Townsend,S .E .,S u,F .W .,A therton,J .M .a ndA llison,J .P .( 1994):S pecificitya ndl ongevityo fa ntitumori mmuner esponsesi nducedb yB 7-transfectedt umors.CancerR esearch 54,6 477–83.

    CAS  Google Scholar 

  • Tu,S .M .,M illikan,R .E .,M engistu,B .,D elpassand,E .S .,A mato,R .J .,P agliaro,L .C .,D aliani,D .,P apandreou,C .N .,S mith,T .L .,K im,J .,P odoloff,D .A .a ndL ogothetis,C .J .( 2001):B one-targetedt herapyf ora dvanceda ndrogen-independentc arcinomao ft hep rostate:a r andomisedp haseI It rial.Lancet 357,3 36–41.

    PubMed  CAS  Google Scholar 

  • Turner,S .L .,G ruenewald,S .,S pry,N .a ndG ebski,V .( 2001):L essp aind oese qualb etterq ualityo fl ifef ollowings trontium-89t herapyf orm etastaticp rostatec ancer.BritishJ ournalo fC ancer 84,2 97–302.

    CAS  Google Scholar 

  • Tuxhorn,J .A .,A yala,G .E .a ndR owley,D .R .( 2001):R eactives tromai np rostatec ancerp rogression.Journalo fU rology 166,2 472–83.

    CAS  Google Scholar 

  • Tuxhorn,J .A .,A yala,G .E .,S mith,M .J .,S mith,V .C .,D ang,T .D .a ndR owley,D .R .( 2002):R eactives tromai nh umanp rostatec ancer:i nductiono fm yofibroblastp henotypea nde xtracellularm atrixr emodeling.ClinicalC ancerR esearch 8,2 912–23.

    CAS  Google Scholar 

  • vand erP oel,H .G .,M olenaar,B .,v anB eusechem,V .W .,H aisma,H .J .,R odriguez,R .,C uriel,D .T .a ndG erritsen,W .R .( 2002):E pidermalg rowthf actorr eceptort argetingo fr eplicationc ompetenta denoviruse nhancesc ytotoxicityi nb ladderc ancer.Journalo fU rology 168,2 66–72.

    Google Scholar 

  • Varani,J .,D ame,M .K .,W ojno,K .,S chuger,L .a ndJ ohnson,K .J .( 1999):C haracteristicso fn onmalignanta ndm alignanth umanp rostatei no rganc ulture.LaboratoryI nvestigation 79,7 23–31.

    CAS  Google Scholar 

  • Varner,J .A .a ndC heresh,D .A .( 1996):I ntegrinsa ndc ancer.CurrentO pinionsi nC ellB iology 8,7 24–30.

    CAS  Google Scholar 

  • Vieweg,J .,R osenthal,F .M .,B annerji,R .,H eston,W .D .,F air,W .R .,G ansbacher,B .a ndG ilboa,E .( 1994):I mmunotherapyo fp rostatec anceri nt heD unningr atm odel:u seo fc ytokineg enem odifiedt umorv accines.CancerR esearch 54,1 760–5.

    CAS  Google Scholar 

  • Walker,J .R .,M cGeagh,K .G .,S undaresan,P .,J orgensen,T .J .,R abkin,S .D .a ndM artuza,R .L.( 1999):L ocala nds ystemict herapyo fh umanp rostatea denocarcinomaw itht hec onditionallyr eplicatingh erpess implexv irusv ectorG 207.HumanG eneT herapy 10,2 237–43.

    CAS  Google Scholar 

  • Waltregny,D .,B ellahcene,A .,V anR iet,I .,F isher,L .W .,Y oung,M .,F ernandez,P .,D ewe,W .,d eL evai,J .a ndC astronovo,V .( 1998):P rognosticv alueo fb ones ialoproteine xpressioni nc linicallyl ocalizedh umanp rostatec ancer.Journalo ft heN ationalC ancerI nstitute,90,1 000–8.

    Google Scholar 

  • Wang,J .M .,D eng,X .,G ong,W .a ndS u,S .( 1998):C hemokinesa ndt heirr olei nt umorg rowtha ndm etastasis.Journalo fI mmunologicalM ethods 220,1 –17.

    CAS  Google Scholar 

  • Wang,R .F .,R obbins,P .F .,K awakami,Y .,K ang,X .Q .a ndR osenberg,S .A .( 1995):I dentificationo fa g enee ncodinga m elanomat umora ntigenr ecognizedb yH LA-A31restrictedt umor-infiltratingl ymphocytes.Journalo fE xperimentalM edicine 181,7 99–804.

    CAS  Google Scholar 

  • Waxman,D .J .,C hen,L .,H echt,J .E .a ndJ ounaidi,Y .( 1999):C ytochromeP 450-basedc ancerg enet herapy:r ecenta dvancesa ndf uturep rospects.D rugM etabR ev31,5 03–22.

    CAS  Google Scholar 

  • Weber,G .F .( 2001):T hem etastasisg eneo steopontin:a c andidatet argetf orc ancert herapy.BiochimB iophysA cta 1552,6 1–85.

    CAS  Google Scholar 

  • Wei,M .X .,T amiya,T .,H urford,R .K .,J r.,B oviatsis,E .J .,T epper,R .I .a ndC hiocca,E .A .( 1995):E nhancemento fi nterleukin-4-mediatedt umorr egressioni na thymicm iceb yi ns itur etroviralg enet ransfer.HumanG eneT herapy 6,4 37–43.

    CAS  Google Scholar 

  • Wernert,N .( 1997):T hem ultipler oleso ft umours troma.VirchowsA rch 430,4 33–43.

    CAS  Google Scholar 

  • Wesseling,J .G .,B osma,P .J .,K rasnykh,V .,K ashentseva,E .A .,B lackwell,J .L .,R eynolds,P .N.,L i,H .,P arameshwar,M .,V ickers,S .M .,J affee,E .M .,H uibregtse,K .,C uriel,D .T .a ndD mitriev,I .( 2001):I mprovedg enet ransfere fficiencyt op rimarya nde stablishedh umanp ancreaticc arcinomat argetc ellsv iae pidermalg rowthf actorr eceptora ndi ntegrintargeteda denoviralv ectors.GeneT herapy 8,9 69–76.

    CAS  Google Scholar 

  • Weyel,D .,S edlacek,H .H .,M uller,R .a ndB russelbach,S .( 2000):S ecretedh umanb etaglucuronidase:a n ovelt oolf org ene-directede nzymep rodrugt herapy.GeneT herapy7 ,2 24–31.

    CAS  Google Scholar 

  • Wickham,T .J .( 2000):T argetinga denovirus.GeneT herapy 7,1 10–4.

    CAS  Google Scholar 

  • Wickham,T .J .,M athias,P .,C heresh,D .A .a ndN emerow,G .R .( 1993):I ntegrinsa lphav b eta3 a nda lphav b eta5 p romotea denovirusi nternalizationb utn otv irusa ttachment.Cell 73,3 09–19.

    PubMed  CAS  Google Scholar 

  • Wickham,T .J .,S egal,D .M .,R oelvink,P .W .,C arrion,M .E .,L izonova,A .,L ee,G .M .a ndK ovesdi,I .( 1996):T argeteda denovirusg enet ransfert oe ndotheliala nds moothm usclec ellsb yu singb ispecifica ntibodies.Journalo fV irology 70,6 831–8.

    CAS  Google Scholar 

  • Wildner,O .,M orris,J .C .,V ahanian,N .N .,F ord,H .,J r.,R amsey,W .J .a ndB laese,R .M .( 1999):A denoviralv ectorsc apableo fr eplicationi mprovet hee fficacyo fH SVtk/GCVs uicideg enet herapyo fc ancer.GeneT herapy 6,5 7–62.

    CAS  Google Scholar 

  • Wojtowicz-Praga,S .( 1997):R eversalo ft umor-inducedi mmunosuppression:a n ewa pproacht oc ancert herapy.Journalo fI mmunotherapy 20,1 65–77.

    CAS  Google Scholar 

  • Wong,Y .C .a ndW ang,Y .Z .( 2000):G rowthf actorsa nde pithelial-stromali nteractionsi np rostatec ancerd evelopment.IntR evC ytol 199,6 5–116.

    CAS  Google Scholar 

  • Wu,H .C .,H sieh,J .T .,G leave,M .E .,B rown,N .M .,P athak,S .a ndC hung,L .W .( 1994):D erivationo fa ndrogen-independenth umanL NCaPp rostaticc ancerc ells ublines:r oleo fb ones tromalc ells.InternationalJ ournalo fC ancer 57,4 06–12.

    CAS  Google Scholar 

  • Wu,L .,M atherly,J .,S mallwood,A .,A dams,J .Y .,B illick,E .,B elldegrun,A .a ndC arey,M .( 2001):C himericP SAe nhancerse xhibita ugmenteda ctivityi np rostatec ancerg enet herapyv ectors.GeneT herapy 8,1 416–26.

    CAS  Google Scholar 

  • Wu,T .T .,S ikes,R .A .,C ui,Q .,T halmann,G .N .,K ao,C .,M urphy,C .F .,Y ang,H .,Z hau,H .E .,B alian,G .a ndC hung,L .W .( 1998):E stablishingh umanp rostatec ancerc ellx enograftsi nb one:i nductiono fo steoblasticr eactionb yp rostate-specifica ntigenproducingt umorsi na thymica ndS CID/bgm iceu singL NCaPa ndl ineage-derivedm etastatics ublines.InternationalJ ournalo fC ancer 11,8 87–94.

    Google Scholar 

  • Xu,J .,K alos,M .,S tolk,J .A .,Z asloff,E .J .,Z hang,X .,H oughton,R .L .,F ilho,A .M .,N olasco,M .,B adaro,R .a ndR eed,S .G .( 2001):I dentificationa ndc haracterizationo fp rostein,a n ovelp rostate-specificp rotein.CancerR esearch 61,1 563–8.

    CAS  Google Scholar 

  • Xu,J .,S tolk,J .A .,Z hang,X .,S ilva,S .J .,H oughton,R .L .,M atsumura,M .,V edvick,T .S .,L eslie,K .B .,B adaro,R .a ndR eed,S .G .( 2000):I dentificationo fd ifferentiallye xpressedg enesi nh umanp rostatec anceru sings ubtractiona ndm icroarray.CancerR esearch 60,1 677–82.

    CAS  Google Scholar 

  • Yamamoto,M .,A lemany,R .,A dachi,Y .,G rizzle,W .E .a ndC uriel,D .T .( 2001):C haracterizationo ft hec yclooxygenase-2p romoteri na na denoviralv ectora ndi tsa pplicationf ort hem itigationo ft oxicityi ns uicideg enet herapyo fg astrointestinalc ancers.MolecularT herapy 3,3 85–94.

    CAS  Google Scholar 

  • Yang,Y .,J ooss,K .U .,S u,Q .,E rtl,H .C .a ndW ilson,J .M .( 1996):I mmuner esponsest ov irala ntigensv ersust ransgenep roducti nt hee liminationo fr ecombinanta denovirusinfectedh epatocytesi nv ivo.GeneT herapy 3,1 37–44.

    Google Scholar 

  • Yeung,F .a ndC hung,L .W .( 2002):M olecularb asiso fc o-targetingp rostatet umora nds troma.JC ellB iochemS uppl 38,6 5–72.

    Google Scholar 

  • Yeung,F .,L aw,W .K .,Y eh,C .H .,W estendorf,J .J .,Z hang,Y .,W ang,R .,K ao,C .a ndC hung,L .W .( 2002):R egulationo fh umano steocalcinp romoteri nh ormone-independenth umanp rostatec ancerc ells.Journalo fB iologicalC hemistry 277,2 468–76.

    CAS  Google Scholar 

  • Yu,D .C .,C hen,Y .,S eng,M .,D illey,J .a ndH enderson,D .R .( 1999):T hea dditiono fa denovirust ype5 r egionE 3e nablesc alydonv irus7 87t oe liminated istantp rostatet umorx enografts.CancerR esearch 59,4 200–3.

    CAS  Google Scholar 

  • Zabner,J .,F reimuth,P .,P uga,A .,F abrega,A .a ndW elsh,M .J .( 1997):Lack of high affinity fiber receptor activity explains there assistance of ciliated airway epitheliato adenovirus infection.Journalo fC linicalI nvestigation 100,1 144–9.

    CAS  Google Scholar 

  • Zhang,J .,D ai,J .,Q i,Y .,L in,D .L .,S mith,P .,S trayhorn,C .,M izokami,A .,F u,Z .,W estman,J .a ndK eller,E .T .( 2001):O steoprotegerini nhibitsp rostatec ancer-inducedo steoclastogenesisa ndp reventsp rostatet umorg rowthi nt heb one.Journalo fC linicalI nvestigation 107,1 235–44.

    CAS  Google Scholar 

  • Zhang,L .Q .,M ei,Y .F .a ndW adell,G .( 2003):H umana denoviruss erotypes4 a nd1 1s howh igherb indinga ffinitya ndi nfectivityf ore ndotheliala ndc arcinomac elll inest hans erotype5 .Journalo fG eneralV irology 84,6 687–95.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Molecular Urology and Therapeutics Program, Department of Urology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA

    Chia-Ling Hsieh, Hiroyuki Kubo & Leland W. K. Chung

Authors
  1. Chia-Ling Hsieh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiroyuki Kubo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Leland W. K. Chung
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Michigan Comprehensive Cancer Center University of Michigan School of Medicine, University of Michigan, Ann Arbor, Michigan, USA

    Evan T. Keller DVM, PhD (Associate Professor of Urology, Comparative Medicine and Pathology) (Associate Professor of Urology, Comparative Medicine and Pathology)

  2. Emory University School of Medicine, Emory University, Atlanta, Georgia, USA

    Leland W. K. Chung PhD (Professor of Urology, Hematology/Oncology, Biochemistry and the Winship Cancer Institute) (Professor of Urology, Hematology/Oncology, Biochemistry and the Winship Cancer Institute)

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science+Business Media New York

About this chapter

Cite this chapter

Hsieh, CL., Kubo, H., Chung, L.W.K. (2004). Gene Therapy for Prostate Cancer Bone Metastasis. In: Keller, E.T., Chung, L.W.K. (eds) The Biology of Skeletal Metastases. Cancer Treatment and Research, vol 118. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-9129-4_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-9129-4_11

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-4803-0

  • Online ISBN: 978-1-4419-9129-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation